Two years ago, James Glazier attended a medical conference in Illinois where he heard a doctor speak on the lack of an economical and reliable method of continuous testing for the blood disease sepsis.
From: www.courier-journal.com
Indiana firm to market biosensors
Posted by Ruslan Abuzant at 5:00 AM
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment